TrialJournal of clinical hypertension (Greenwich, Conn.)2026

Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial.

Hyo-Suk Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.